Absci Founder & CEO Sean McClain will discuss the strategic partnership at the 43rd Annual J.P.Morgan Healthcare Conference on Wednesday January 15th at 4:30pm PT. Absci and AMD will showcase the ...

Absci's CEO Sean McClain will address the partnership at the upcoming J.P. Morgan Healthcare Conference on January 15, 2025. Both companies are excited about the potential to revolutionize the ...

Sean McClain, Absci’s Founder and CEO, said, “AMD high-performance compute will enable us to further the development of next-generation antibody therapeutics, and we are excited about the ...

As part of AMD’s investment in Absci, the company will move toward greater use of AMD’s GPUs, said the company’s founder and Chief Executive Sean McClain. Absci currently uses over 470 AI ...

Absci Founder & CEO Sean McClain will discuss the strategic partnership at the 43rd Annual J.P.Morgan Healthcare Conference on Wednesday January 15th at 4:30pm PT. Absci and AMD will showcase the ...

Absci's Founder & CEO, Sean McClain, highlighted the importance of the partnership during his presentation at the 43rd Annual J.P. Morgan Healthcare Conference. He emphasized that working with AMD ...

“AMD high-performance compute will enable us to further the development of next-generation antibody therapeutics,” said Absci founder and Chief Executive Officer Sean McClain. Absci will use ...

Sean McClain, Absci’s Founder and CEO, said, “AMD high-performance compute will enable us to further the development of next-generation antibody therapeutics, and we are excited about the potential ...

“At Absci, we’re constantly pushing the boundaries of innovation to bring better biologics to patients faster,” said Sean McClain, Founder and CEO of Absci. “By combining Absci’s AI de ...